Menu
GWAS Study

Inherited GATA3 variants are associated with Ph-like childhood acute lymphoblastic leukemia and risk of relapse.

Perez-Andreu V, Roberts KG, Harvey RC et al.

24141364 PubMed ID
GWAS Study Type
13163 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

PV
Perez-Andreu V
RK
Roberts KG
HR
Harvey RC
YW
Yang W
CC
Cheng C
PD
Pei D
XH
Xu H
GJ
Gastier-Foster J
ES
E S
LJ
Lim JY
CI
Chen IM
FY
Fan Y
DM
Devidas M
BM
Borowitz MJ
SC
Smith C
NG
Neale G
BE
Burchard EG
TD
Torgerson DG
KF
Klussmann FA
VC
Villagran CR
WN
Winick NJ
CB
Camitta BM
RE
Raetz E
WB
Wood B
YF
Yue F
CW
Carroll WL
LE
Larsen E
BW
Bowman WP
LM
Loh ML
DM
Dean M
BD
Bhojwani D
PC
Pui CH
EW
Evans WE
RM
Relling MV
HS
Hunger SP
WC
Willman CL
MC
Mullighan CG
YJ
Yang JJ
Chapter II

Abstract

Summary of the research findings

Recent genomic profiling of childhood acute lymphoblastic leukemia (ALL) identified a high-risk subtype with an expression signature resembling that of Philadelphia chromosome-positive ALL and poor prognosis (Ph-like ALL). However, the role of inherited genetic variation in Ph-like ALL pathogenesis remains unknown. In a genome-wide association study (GWAS) of 511 ALL cases and 6,661 non-ALL controls, we identified a susceptibility locus for Ph-like ALL (GATA3, rs3824662; P = 2.17 × 10(-14), odds ratio (OR) = 3.85 for Ph-like ALL versus non-ALL; P = 1.05 × 10(-8), OR = 3.25 for Ph-like ALL versus non-Ph-like ALL), with independent validation. The rs3824662 risk allele was associated with somatic lesions underlying Ph-like ALL (CRLF2 rearrangement, JAK gene mutation and IKZF1 deletion) and with variation in GATA3 expression. Finally, genotype at the GATA3 SNP was also associated with early treatment response and risk of ALL relapse. Our results provide insights into interactions between inherited and somatic variants and their role in ALL pathogenesis and prognosis.

75 European, Asian, African American, and Hispanic ancestry Ph-like ALL cases, 436 European, Asian, African American, and Hispanic ancestry non Ph-like ALL cases, 6,661 European, Asian, African American, and Hispanic ancestry non-ALL controls

Chapter III

Study Statistics

Key metrics and study information

13163
Total Participants
GWAS
Study Type
Yes
Replicated
32 European, Asian, African American, and Hispanic ancestry Ph-like ALL cases, 139 European, Asian, African American, and Hispanic ancestry non Ph-like ALL cases, 3,647 European ancestry non-ALL controls, 1,228 African American non-ALL controls, 920 Hispanic non-ALL controls, 25 Native American non-ALL controls
Replication Participants
African American or Afro-Caribbean, Asian unspecified, African American or Afro-Caribbean, European, Hispanic or Latin American, Asian unspecified, Hispanic or Latin American, Native American, European, African American or Afro-Caribbean
Ancestry
U.S., Guatemala
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.